Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Virus Replication | 9 | 2016 | 2458 | 0.880 |
Why?
|
| Mycobacterium tuberculosis | 6 | 2016 | 1930 | 0.770 |
Why?
|
| HIV-1 | 14 | 2012 | 6961 | 0.640 |
Why?
|
| Antigens, Differentiation | 2 | 2016 | 921 | 0.430 |
Why?
|
| Monocytes | 3 | 2022 | 2605 | 0.400 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 582 | 0.310 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 70 | 0.270 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1890 | 0.270 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2020 | 4352 | 0.260 |
Why?
|
| Gene Products, tat | 1 | 2006 | 111 | 0.260 |
Why?
|
| Simian immunodeficiency virus | 4 | 2001 | 814 | 0.250 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3703 | 0.220 |
Why?
|
| Tuberculosis | 2 | 2012 | 2029 | 0.200 |
Why?
|
| Transcription Factors | 4 | 2012 | 12168 | 0.190 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2006 | 633 | 0.190 |
Why?
|
| Lymphotoxin-alpha | 1 | 2020 | 94 | 0.180 |
Why?
|
| HIV-2 | 1 | 2000 | 156 | 0.170 |
Why?
|
| RNA Interference | 2 | 2006 | 2832 | 0.160 |
Why?
|
| Receptors, IgG | 1 | 2022 | 564 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2020 | 4415 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7876 | 0.150 |
Why?
|
| Antigens, Bacterial | 1 | 2004 | 1150 | 0.150 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1183 | 0.150 |
Why?
|
| Reassortant Viruses | 1 | 1997 | 36 | 0.140 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 11928 | 0.140 |
Why?
|
| Immunologic Memory | 1 | 2004 | 1377 | 0.140 |
Why?
|
| Gene Products, gag | 1 | 1997 | 318 | 0.130 |
Why?
|
| Image Cytometry | 1 | 2016 | 53 | 0.130 |
Why?
|
| Trans-Activators | 1 | 2006 | 2857 | 0.130 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2006 | 2204 | 0.120 |
Why?
|
| Cells, Cultured | 6 | 2015 | 19015 | 0.120 |
Why?
|
| Toxoplasma | 1 | 2016 | 159 | 0.120 |
Why?
|
| HIV Infections | 7 | 2016 | 17569 | 0.120 |
Why?
|
| Exodeoxyribonucleases | 1 | 2016 | 191 | 0.120 |
Why?
|
| Hydrogen Peroxide | 2 | 1996 | 740 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2020 | 1854 | 0.120 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 1997 | 925 | 0.120 |
Why?
|
| Macrophages | 3 | 2016 | 5799 | 0.110 |
Why?
|
| Interferon-beta | 1 | 2016 | 349 | 0.110 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 348 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2015 | 23645 | 0.110 |
Why?
|
| Phagocytosis | 2 | 2016 | 1530 | 0.110 |
Why?
|
| Endosomes | 1 | 2015 | 522 | 0.100 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2012 | 44 | 0.100 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2012 | 75 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 588 | 0.100 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2011 | 86 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1606 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 5797 | 0.090 |
Why?
|
| Acetylation | 2 | 2020 | 1056 | 0.090 |
Why?
|
| Jurkat Cells | 2 | 2006 | 740 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2004 | 4648 | 0.090 |
Why?
|
| Protein Transport | 1 | 2015 | 1951 | 0.080 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 7608 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 294 | 0.080 |
Why?
|
| Cell Line | 7 | 2006 | 15597 | 0.080 |
Why?
|
| Reactive Oxygen Species | 2 | 1996 | 2149 | 0.080 |
Why?
|
| DNA, Single-Stranded | 1 | 1990 | 351 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1469 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2004 | 4573 | 0.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 582 | 0.070 |
Why?
|
| Gene Expression | 1 | 2020 | 7598 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2451 | 0.070 |
Why?
|
| Genes, env | 2 | 1997 | 96 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 1990 | 557 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 3428 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4283 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2006 | 3074 | 0.060 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 120 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5902 | 0.060 |
Why?
|
| Chimera | 2 | 2016 | 454 | 0.060 |
Why?
|
| DNA Damage | 2 | 1993 | 2469 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 148 | 0.060 |
Why?
|
| Species Specificity | 1 | 2009 | 2415 | 0.060 |
Why?
|
| Biological Transport | 1 | 2009 | 2085 | 0.060 |
Why?
|
| Tuberculin | 1 | 2004 | 64 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 335 | 0.060 |
Why?
|
| Clonal Anergy | 1 | 2004 | 169 | 0.050 |
Why?
|
| Histones | 2 | 2020 | 2601 | 0.050 |
Why?
|
| DNA, Viral | 3 | 2006 | 2204 | 0.050 |
Why?
|
| Genes, gag | 2 | 2005 | 59 | 0.050 |
Why?
|
| Software | 1 | 2016 | 4478 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10873 | 0.050 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 130 | 0.050 |
Why?
|
| Protein Binding | 2 | 2020 | 9343 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 2020 | 1162 | 0.050 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2022 | 93 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2022 | 227 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2006 | 13421 | 0.050 |
Why?
|
| Monkey Diseases | 1 | 2000 | 71 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2009 | 2885 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 17622 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2012 | 3080 | 0.040 |
Why?
|
| Gene Products, env | 2 | 1997 | 250 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3228 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3772 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2020 | 12800 | 0.040 |
Why?
|
| Superoxide Dismutase | 2 | 1993 | 596 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 5505 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2000 | 912 | 0.040 |
Why?
|
| Humans | 20 | 2022 | 768166 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1903 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2004 | 843 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2022 | 540 | 0.030 |
Why?
|
| Macaca mulatta | 2 | 2000 | 2363 | 0.030 |
Why?
|
| Base Sequence | 3 | 2016 | 12421 | 0.030 |
Why?
|
| Cell Division | 1 | 2004 | 4473 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2000 | 545 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 549 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2006 | 6611 | 0.030 |
Why?
|
| Burundi | 1 | 1995 | 12 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2006 | 5403 | 0.030 |
Why?
|
| Macaca | 1 | 1997 | 413 | 0.030 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 1997 | 306 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 3740 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3445 | 0.030 |
Why?
|
| Vagina | 2 | 2016 | 850 | 0.030 |
Why?
|
| Cytokines | 2 | 2011 | 7453 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 1367 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 838 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2001 | 2614 | 0.030 |
Why?
|
| Xanthine Oxidase | 1 | 1993 | 69 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2001 | 2872 | 0.030 |
Why?
|
| Catalase | 1 | 1993 | 215 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 1524 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2016 | 577 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2016 | 1081 | 0.020 |
Why?
|
| Binding Sites | 1 | 2020 | 6020 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2179 | 0.020 |
Why?
|
| Phylogeny | 2 | 1996 | 2843 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 4206 | 0.020 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2011 | 81 | 0.020 |
Why?
|
| Cholestasis | 1 | 1993 | 385 | 0.020 |
Why?
|
| Europe | 1 | 1997 | 3436 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13671 | 0.020 |
Why?
|
| Animals | 8 | 2016 | 169246 | 0.020 |
Why?
|
| HIV | 1 | 2016 | 1597 | 0.020 |
Why?
|
| Superoxides | 1 | 1990 | 389 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1930 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6124 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 1997 | 10266 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6082 | 0.020 |
Why?
|
| Genes, rev | 1 | 2005 | 13 | 0.020 |
Why?
|
| Genes, vif | 1 | 2005 | 15 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9615 | 0.010 |
Why?
|
| Biological Therapy | 1 | 2005 | 140 | 0.010 |
Why?
|
| Lentivirus | 1 | 2005 | 518 | 0.010 |
Why?
|
| Female | 5 | 2016 | 397192 | 0.010 |
Why?
|
| DNA Probes | 1 | 2001 | 542 | 0.010 |
Why?
|
| World Health Organization | 2 | 1996 | 1329 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 2560 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 5755 | 0.010 |
Why?
|
| Mice | 2 | 2016 | 82029 | 0.010 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 1996 | 96 | 0.010 |
Why?
|
| Proviruses | 1 | 1997 | 320 | 0.010 |
Why?
|
| Algorithms | 1 | 2016 | 14164 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1994 | 152 | 0.010 |
Why?
|
| Viremia | 1 | 1997 | 726 | 0.010 |
Why?
|
| Thailand | 1 | 1994 | 288 | 0.010 |
Why?
|
| Male | 1 | 2012 | 364719 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 1297 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2005 | 3073 | 0.010 |
Why?
|
| Rwanda | 1 | 1994 | 671 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1996 | 1134 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2748 | 0.010 |
Why?
|
| Brazil | 1 | 1994 | 1250 | 0.010 |
Why?
|
| Uganda | 1 | 1994 | 1361 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1993 | 1888 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1993 | 2323 | 0.000 |
Why?
|
| Mutation | 1 | 2005 | 30238 | 0.000 |
Why?
|
| Genotype | 1 | 1994 | 13045 | 0.000 |
Why?
|
| Rats | 1 | 1993 | 23760 | 0.000 |
Why?
|
| Phenotype | 1 | 1994 | 16726 | 0.000 |
Why?
|
Concepts
(173)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_